node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
CERS2 | ELOVL3 | ENSP00000271688 | ENSP00000359022 | ceramide synthase 2; Suppresses the growth of cancer cells. May be involved in sphingolipid synthesis | ELOVL fatty acid elongase 3; Condensing enzyme that elongates saturated and monounsaturated very long chain fatty acids (VLCFAs). Highest activity toward C18 acyl-CoAs, especially C18-0 acyl-CoAs | 0.771 |
CERS2 | HSD17B12 | ENSP00000271688 | ENSP00000278353 | ceramide synthase 2; Suppresses the growth of cancer cells. May be involved in sphingolipid synthesis | hydroxysteroid (17-beta) dehydrogenase 12; Catalyzes the transformation of estrone (E1) into estradiol (E2), suggesting a central role in estrogen formation. Its strong expression in ovary and mammary gland suggest that it may constitute the major enzyme responsible for the conversion of E1 to E2 in women. Also has 3-ketoacyl-CoA reductase activity, reducing both long chain 3-ketoacyl-CoAs and long chain fatty acyl-CoAs, suggesting a role in long fatty acid elongation | 0.649 |
CERS3 | ELOVL3 | ENSP00000284382 | ENSP00000359022 | ceramide synthase 3; May be involved in sphingolipid synthesis or its regulation (By similarity) | ELOVL fatty acid elongase 3; Condensing enzyme that elongates saturated and monounsaturated very long chain fatty acids (VLCFAs). Highest activity toward C18 acyl-CoAs, especially C18-0 acyl-CoAs | 0.533 |
ELOVL3 | CERS2 | ENSP00000359022 | ENSP00000271688 | ELOVL fatty acid elongase 3; Condensing enzyme that elongates saturated and monounsaturated very long chain fatty acids (VLCFAs). Highest activity toward C18 acyl-CoAs, especially C18-0 acyl-CoAs | ceramide synthase 2; Suppresses the growth of cancer cells. May be involved in sphingolipid synthesis | 0.771 |
ELOVL3 | CERS3 | ENSP00000359022 | ENSP00000284382 | ELOVL fatty acid elongase 3; Condensing enzyme that elongates saturated and monounsaturated very long chain fatty acids (VLCFAs). Highest activity toward C18 acyl-CoAs, especially C18-0 acyl-CoAs | ceramide synthase 3; May be involved in sphingolipid synthesis or its regulation (By similarity) | 0.533 |
ELOVL3 | HDAC3 | ENSP00000359022 | ENSP00000302967 | ELOVL fatty acid elongase 3; Condensing enzyme that elongates saturated and monounsaturated very long chain fatty acids (VLCFAs). Highest activity toward C18 acyl-CoAs, especially C18-0 acyl-CoAs | histone deacetylase 3; Responsible for the deacetylation of lysine residues on the N-terminal part of the core histones (H2A, H2B, H3 and H4), and some other non-histone substrates. Histone deacetylation gives a tag for epigenetic repression and plays an important role in transcriptional regulation, cell cycle progression and developmental events. Histone deacetylases act via the formation of large multiprotein complexes. Probably participates in the regulation of transcription through its binding to the zinc-finger transcription factor YY1; increases YY1 repression activity. Required [...] | 0.902 |
ELOVL3 | HSD17B12 | ENSP00000359022 | ENSP00000278353 | ELOVL fatty acid elongase 3; Condensing enzyme that elongates saturated and monounsaturated very long chain fatty acids (VLCFAs). Highest activity toward C18 acyl-CoAs, especially C18-0 acyl-CoAs | hydroxysteroid (17-beta) dehydrogenase 12; Catalyzes the transformation of estrone (E1) into estradiol (E2), suggesting a central role in estrogen formation. Its strong expression in ovary and mammary gland suggest that it may constitute the major enzyme responsible for the conversion of E1 to E2 in women. Also has 3-ketoacyl-CoA reductase activity, reducing both long chain 3-ketoacyl-CoAs and long chain fatty acyl-CoAs, suggesting a role in long fatty acid elongation | 0.635 |
ELOVL3 | NCOR1 | ENSP00000359022 | ENSP00000268712 | ELOVL fatty acid elongase 3; Condensing enzyme that elongates saturated and monounsaturated very long chain fatty acids (VLCFAs). Highest activity toward C18 acyl-CoAs, especially C18-0 acyl-CoAs | nuclear receptor corepressor 1; Mediates transcriptional repression by certain nuclear receptors. Part of a complex which promotes histone deacetylation and the formation of repressive chromatin structures which may impede the access of basal transcription factors | 0.910 |
ELOVL3 | NR1D1 | ENSP00000359022 | ENSP00000246672 | ELOVL fatty acid elongase 3; Condensing enzyme that elongates saturated and monounsaturated very long chain fatty acids (VLCFAs). Highest activity toward C18 acyl-CoAs, especially C18-0 acyl-CoAs | nuclear receptor subfamily 1, group D, member 1; Functions as a constitutive transcriptional repressor. In collaboration with SP1, activates GJA1 transcription (By similarity). Possible receptor for triiodothyronine | 0.912 |
ELOVL3 | PRDM16 | ENSP00000359022 | ENSP00000270722 | ELOVL fatty acid elongase 3; Condensing enzyme that elongates saturated and monounsaturated very long chain fatty acids (VLCFAs). Highest activity toward C18 acyl-CoAs, especially C18-0 acyl-CoAs | PR domain containing 16; Binds DNA and functions as a transcriptional regulator. Functions in the differentiation of brown adipose tissue (BAT) which is specialized in dissipating chemical energy in the form of heat in response to cold or excess feeding while white adipose tissue (WAT) is specialized in the storage of excess energy and the control of systemic metabolism. Together with CEBPB, regulates the differentiation of myoblastic precursors into brown adipose cells. Functions also as a repressor of TGF-beta signaling. Isoform 4 may regulate granulocytes differentiation | 0.541 |
ELOVL3 | SCD | ENSP00000359022 | ENSP00000359380 | ELOVL fatty acid elongase 3; Condensing enzyme that elongates saturated and monounsaturated very long chain fatty acids (VLCFAs). Highest activity toward C18 acyl-CoAs, especially C18-0 acyl-CoAs | stearoyl-CoA desaturase (delta-9-desaturase) | 0.769 |
ELOVL3 | SCD5 | ENSP00000359022 | ENSP00000316329 | ELOVL fatty acid elongase 3; Condensing enzyme that elongates saturated and monounsaturated very long chain fatty acids (VLCFAs). Highest activity toward C18 acyl-CoAs, especially C18-0 acyl-CoAs | stearoyl-CoA desaturase 5; Fatty acid delta-9-desaturase that introduces a double bond in fatty acyl-coenzyme A at the delta-9 position | 0.651 |
ELOVL3 | UCP1 | ENSP00000359022 | ENSP00000262999 | ELOVL fatty acid elongase 3; Condensing enzyme that elongates saturated and monounsaturated very long chain fatty acids (VLCFAs). Highest activity toward C18 acyl-CoAs, especially C18-0 acyl-CoAs | uncoupling protein 1 (mitochondrial, proton carrier); UCP are mitochondrial transporter proteins that create proton leaks across the inner mitochondrial membrane, thus uncoupling oxidative phosphorylation from ATP synthesis. As a result, energy is dissipated in the form of heat | 0.569 |
HDAC3 | ELOVL3 | ENSP00000302967 | ENSP00000359022 | histone deacetylase 3; Responsible for the deacetylation of lysine residues on the N-terminal part of the core histones (H2A, H2B, H3 and H4), and some other non-histone substrates. Histone deacetylation gives a tag for epigenetic repression and plays an important role in transcriptional regulation, cell cycle progression and developmental events. Histone deacetylases act via the formation of large multiprotein complexes. Probably participates in the regulation of transcription through its binding to the zinc-finger transcription factor YY1; increases YY1 repression activity. Required [...] | ELOVL fatty acid elongase 3; Condensing enzyme that elongates saturated and monounsaturated very long chain fatty acids (VLCFAs). Highest activity toward C18 acyl-CoAs, especially C18-0 acyl-CoAs | 0.902 |
HDAC3 | NCOR1 | ENSP00000302967 | ENSP00000268712 | histone deacetylase 3; Responsible for the deacetylation of lysine residues on the N-terminal part of the core histones (H2A, H2B, H3 and H4), and some other non-histone substrates. Histone deacetylation gives a tag for epigenetic repression and plays an important role in transcriptional regulation, cell cycle progression and developmental events. Histone deacetylases act via the formation of large multiprotein complexes. Probably participates in the regulation of transcription through its binding to the zinc-finger transcription factor YY1; increases YY1 repression activity. Required [...] | nuclear receptor corepressor 1; Mediates transcriptional repression by certain nuclear receptors. Part of a complex which promotes histone deacetylation and the formation of repressive chromatin structures which may impede the access of basal transcription factors | 0.999 |
HDAC3 | NR1D1 | ENSP00000302967 | ENSP00000246672 | histone deacetylase 3; Responsible for the deacetylation of lysine residues on the N-terminal part of the core histones (H2A, H2B, H3 and H4), and some other non-histone substrates. Histone deacetylation gives a tag for epigenetic repression and plays an important role in transcriptional regulation, cell cycle progression and developmental events. Histone deacetylases act via the formation of large multiprotein complexes. Probably participates in the regulation of transcription through its binding to the zinc-finger transcription factor YY1; increases YY1 repression activity. Required [...] | nuclear receptor subfamily 1, group D, member 1; Functions as a constitutive transcriptional repressor. In collaboration with SP1, activates GJA1 transcription (By similarity). Possible receptor for triiodothyronine | 0.959 |
HSD17B12 | CERS2 | ENSP00000278353 | ENSP00000271688 | hydroxysteroid (17-beta) dehydrogenase 12; Catalyzes the transformation of estrone (E1) into estradiol (E2), suggesting a central role in estrogen formation. Its strong expression in ovary and mammary gland suggest that it may constitute the major enzyme responsible for the conversion of E1 to E2 in women. Also has 3-ketoacyl-CoA reductase activity, reducing both long chain 3-ketoacyl-CoAs and long chain fatty acyl-CoAs, suggesting a role in long fatty acid elongation | ceramide synthase 2; Suppresses the growth of cancer cells. May be involved in sphingolipid synthesis | 0.649 |
HSD17B12 | ELOVL3 | ENSP00000278353 | ENSP00000359022 | hydroxysteroid (17-beta) dehydrogenase 12; Catalyzes the transformation of estrone (E1) into estradiol (E2), suggesting a central role in estrogen formation. Its strong expression in ovary and mammary gland suggest that it may constitute the major enzyme responsible for the conversion of E1 to E2 in women. Also has 3-ketoacyl-CoA reductase activity, reducing both long chain 3-ketoacyl-CoAs and long chain fatty acyl-CoAs, suggesting a role in long fatty acid elongation | ELOVL fatty acid elongase 3; Condensing enzyme that elongates saturated and monounsaturated very long chain fatty acids (VLCFAs). Highest activity toward C18 acyl-CoAs, especially C18-0 acyl-CoAs | 0.635 |
NCOR1 | ELOVL3 | ENSP00000268712 | ENSP00000359022 | nuclear receptor corepressor 1; Mediates transcriptional repression by certain nuclear receptors. Part of a complex which promotes histone deacetylation and the formation of repressive chromatin structures which may impede the access of basal transcription factors | ELOVL fatty acid elongase 3; Condensing enzyme that elongates saturated and monounsaturated very long chain fatty acids (VLCFAs). Highest activity toward C18 acyl-CoAs, especially C18-0 acyl-CoAs | 0.910 |
NCOR1 | HDAC3 | ENSP00000268712 | ENSP00000302967 | nuclear receptor corepressor 1; Mediates transcriptional repression by certain nuclear receptors. Part of a complex which promotes histone deacetylation and the formation of repressive chromatin structures which may impede the access of basal transcription factors | histone deacetylase 3; Responsible for the deacetylation of lysine residues on the N-terminal part of the core histones (H2A, H2B, H3 and H4), and some other non-histone substrates. Histone deacetylation gives a tag for epigenetic repression and plays an important role in transcriptional regulation, cell cycle progression and developmental events. Histone deacetylases act via the formation of large multiprotein complexes. Probably participates in the regulation of transcription through its binding to the zinc-finger transcription factor YY1; increases YY1 repression activity. Required [...] | 0.999 |